Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in this Registration Statement (Form F-3) and related prospectus of Biondvax Pharmaceuticals Ltd. of our report dated April 17, 2023, with respect to the financial statements of Biondvax Pharmaceuticals Ltd. included in its Annual Report (Form 10-K) for the year ended December 31, 2022, filed with the Securities and Exchange Commission.
/s/ Kost Forer Gabbay & Kasierer | |
Kost Forer Gabbay & Kasierer |
A member firm of Ernst & Young Global
Tel Aviv, Israel
August 18, 2023